Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending August 24, 2018. The document serves as a transaction notification regarding insider trading activity rather than a comprehensive financial report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific securities transaction.
Material Changes and Transaction Details
The filing discloses a sale of ordinary shares by a Person Discharging Managerial Responsibilities (PDMR). The specific details are as follows:
- Person: Ms. C Thomas, SVP, Human Resources.
- Transaction Type: Sale of Ordinary Shares (25 pence each).
- Volume: 30,000 shares.
- Price: £16.0410 per share.
- Date: August 23, 2018.
- Exchange: London Stock Exchange (XLON).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is strictly a regulatory notification of the share sale described above.
Investor Verification Checklist
- Verify the total number of shares held by Ms. C Thomas post-transaction to assess remaining exposure.
- Confirm if this transaction was part of a pre-arranged trading plan (Rule 10b5-1 equivalent).
- Review the broader market context for GSK stock on August 23, 2018, to determine if the sale price was favorable relative to the daily range.